Philip R. Dormitzer MD, PhD

Philip R. Dormitzer is VP and CSO for Viral Vaccines at Pfizer in Pearl River, New York, and a board-certified Internist. After studying anthropology at Harvard College and carrying out a field study of the Efe Pygmies in the Ituri Forest of Zaire, he completed his M.D., Ph.D. in Cancer Biology at Stanford University followed by house-staff training in Internal Medicine at Massachusetts General Hospital and a fellowship in the Harvard Combined Infectious Diseases Training Program. As an Assistant Professor of Pediatrics at Harvard Medical School, Dr. Dormitzer led a structural virology laboratory that determined the structures of the rotavirus neutralization antigens. Before joining Pfizer, Dr. Dormitzer was Head of US Research at Novartis Vaccines. At Novartis, Dr. Dormitzer led projects that included the research component of the Novartis response to the H1N1v influenza pandemic, the most rapid vaccine response in history. He now leads Viral Vaccine R&D at Pfizer.